BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29248133)

  • 21. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
    Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
    Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4.
    Pinheiro C; Miranda-Gonçalves V; Longatto-Filho A; Vicente AL; Berardinelli GN; Scapulatempo-Neto C; Costa RF; Viana CR; Reis RM; Baltazar F; Vazquez VL
    Cell Cycle; 2016 Jun; 15(11):1462-70. PubMed ID: 27105345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis.
    Sheng G; Gao Y; Wu H; Liu Y; Yang Y
    J Orthop Surg Res; 2023 Feb; 18(1):131. PubMed ID: 36814318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue.
    Sotgia F; Whitaker-Menezes D; Martinez-Outschoorn UE; Flomenberg N; Birbe RC; Witkiewicz AK; Howell A; Philp NJ; Pestell RG; Lisanti MP
    Cell Cycle; 2012 Apr; 11(7):1445-54. PubMed ID: 22395432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.
    Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of streptozotocin-induced diabetes on markers of skeletal muscle metabolism and monocarboxylate transporter 1 to monocarboxylate transporter 4 transporters.
    Py G; Lambert K; Milhavet O; Eydoux N; Préfaut C; Mercier J
    Metabolism; 2002 Jul; 51(7):807-13. PubMed ID: 12077722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.
    Polański R; Hodgkinson CL; Fusi A; Nonaka D; Priest L; Kelly P; Trapani F; Bishop PW; White A; Critchlow SE; Smith PD; Blackhall F; Dive C; Morrow CJ
    Clin Cancer Res; 2014 Feb; 20(4):926-937. PubMed ID: 24277449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicompartment metabolism in papillary thyroid cancer.
    Curry JM; Tassone P; Cotzia P; Sprandio J; Luginbuhl A; Cognetti DM; Mollaee M; Domingo M; Pribitkin EA; Keane WM; Zhan TT; Birbe R; Tuluc M; Martinez-Outschoorn U
    Laryngoscope; 2016 Oct; 126(10):2410-2418. PubMed ID: 26666958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone increases lactate transport, monocarboxylate transporter (MCT) 1 and MCT4 in rat skeletal muscle.
    Enoki T; Yoshida Y; Lally J; Hatta H; Bonen A
    J Physiol; 2006 Nov; 577(Pt 1):433-43. PubMed ID: 16959859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical analysis of MCT1, MCT2 and MCT4 expression in rat plantaris muscle.
    Hashimoto T; Masuda S; Taguchi S; Brooks GA
    J Physiol; 2005 Aug; 567(Pt 1):121-9. PubMed ID: 15932892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
    Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
    Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration.
    De Saedeleer CJ; Porporato PE; Copetti T; Pérez-Escuredo J; Payen VL; Brisson L; Feron O; Sonveaux P
    Oncogene; 2014 Jul; 33(31):4060-8. PubMed ID: 24166504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma.
    Koh YW; Jeon YK; Yoon DH; Suh C; Huh J
    Tumour Biol; 2016 Jun; 37(6):7507-14. PubMed ID: 26678894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report).
    Dell'Anno I; Barone E; Mutti L; Rassl DM; Marciniak SJ; Silvestri R; Landi S; Gemignani F
    J Transl Med; 2020 Sep; 18(1):341. PubMed ID: 32887638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.
    Quesada AE; Assylbekova B; Jabcuga CE; Zhang R; Covinsky M; Rios A; Nguyen ND; Brown RE
    Int J Clin Exp Pathol; 2015; 8(10):13241-8. PubMed ID: 26722524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.
    Huhta H; Helminen O; Palomäki S; Kauppila JH; Saarnio J; Lehenkari PP; Karttunen TJ
    Oncotarget; 2017 Apr; 8(14):22894-22902. PubMed ID: 28206968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.
    Vari F; Arpon D; Keane C; Hertzberg MS; Talaulikar D; Jain S; Cui Q; Han E; Tobin J; Bird R; Cross D; Hernandez A; Gould C; Birch S; Gandhi MK
    Blood; 2018 Apr; 131(16):1809-1819. PubMed ID: 29449276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development.
    Wilde L; Roche M; Domingo-Vidal M; Tanson K; Philp N; Curry J; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):198-203. PubMed ID: 29248131
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Chou CH; Chiang CF; Yang CC; Liu YC; Chang SR; Chang KW; Lin SC
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.